ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2648

Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy: A Retrospective, Single Center Experience over a 21 Years’ Period

Francesco Muratore1, Luigi Boiardi 2, Alberto Cavazza 3, Giacomo Tiengo 4, Raffaella Aldigeri 5, Luca Cimino 6 and Carlo Salvarani 7, 1Division of Rheumatology, Azienda Unita’ Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy, 2Division of Rheumatology, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy, 3Pathology Unit, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy, 4Division of Rheumatology, University of Modena and Reggio Emilia, Modena, Italy, 5Department of Medicine and Surgery, University of Parma, Parma, Italy, 6Ophthalmology Unit, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy, 7Division of Rheumatology, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: temporal arteritis and biopsy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate the association between specimen length and number of sections and the diagnostic yield of temporal artery biopsy (TAB) for giant cell arteritis (GCA).

Methods: A pathologist with expertise in vasculitis and blinded to clinical data and final diagnosis reviewed all TABs performed for suspected GCA at our hospital between January 1991 and December 2012. The biopsies were routinely fixed in formalin and completely embedded in paraffin. Sections of 4 microns thickness were cut from paraffin blocks and stained with hematoxylin-eosin. TABs were classified into three categories: inadequate, when the biopsy did not sample the muscular artery; negative when the temporal artery was devoid of inflammation and positive when the temporal artery showed inflammation, arbitrarily defined as at least 1 aggregate of at least 15 inflammatory cells. The blocks of all the inadequate and negative biopsies were recut, and at least three further slides at deeper levels were stained with hematoxylin-eosin in order to avoid missing skip inflammatory lesions.

Results: 694 TABs were performed in the study period and were reviewed. 32 (4.6%) were classified as inadequate and were excluded from the analysis. Of the remaining 662 TABs [71% female; mean (SD) age, 73.2 (8.8) years], mean (SD) post fixation length was 6.63 (4.42) mm, and median number of sections evaluated was 3 (range 1-33). 382 (58%) TABs were classified as negative and 280 (42%) as positive. Compared with negative TAB, patients with positive TAB were older [mean age (SD) 74 (7.5) years vs 72 (9.6), p=0.009] and there was a trend for female predominance (75% vs 68%, p=0.077). Post fixation length of the specimens was significantly lower in negative compared with positive TAB [mean (SD) 6.37 (4.26) mm vs 6.99 (4.61) respectively, p=0.026]. Piecewise logistic regression identified 5 mm as the TAB length change point for diagnostic sensitivity. Compared with TAB length of < 5 mm, age- and sex-adjusted odds ratio for positive TAB in samples ≥5 mm long were 1.536 (95% confidence interval, 1.108 to 2.130).
The median (IQR) number of sections evaluated were 2 (1-3) for positive TAB and 4 (2-5) for negative TAB, p< 0.0001. In 26/280 (9.3%) positive TABs, the first section was negative, and the inflammation was detected only in deeper sections (the positive section was the second in 14 TABs, the third in 9 and the fourth in 3). In all 26 cases, inflammation detected in deeper section was not transmural, but limited to adventitial or periadventitial small vessels.

Conclusion: Our data confirm that a post fixation TAB length of at least 5 mm should be sufficient to make a histological diagnosis of inflamed temporal artery. According to our data, in order to avoid missing skip inflammatory lesions, at least 3 further sections at deeper levels should be cut and evaluated in all negative TABs.


Disclosure: F. Muratore, None; L. Boiardi, None; A. Cavazza, None; G. Tiengo, None; R. Aldigeri, None; L. Cimino, None; C. Salvarani, None.

To cite this abstract in AMA style:

Muratore F, Boiardi L, Cavazza A, Tiengo G, Aldigeri R, Cimino L, Salvarani C. Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy: A Retrospective, Single Center Experience over a 21 Years’ Period [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/association-between-specimen-length-and-number-of-sections-and-diagnostic-yield-of-temporal-artery-biopsy-a-retrospective-single-center-experience-over-a-21-years-period/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-specimen-length-and-number-of-sections-and-diagnostic-yield-of-temporal-artery-biopsy-a-retrospective-single-center-experience-over-a-21-years-period/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology